Circulating vitamin D concentration and risk of prostate cancer: a dose–response meta-analysis of prospective studies

References

• AttardGParkerCEelesRAProstate cancerLancet201638710013708226074382
   PubMed Web of Science ®Google Scholar
• ItoKProstate cancer in Asian menNat Rev Urol201411419721224595118
   PubMed Web of Science ®Google Scholar
• RitchCRCooksonMSAdvances in the management of castration resistant prostate cancerBMJ2016355i440527754846
   PubMed Web of Science ®Google Scholar
• YapTASmithADFerraldeschiRAl-LazikaniBWorkmanPde BonoJSDrug discovery in advanced prostate cancer: translating biology into therapyNat Rev Drug Discov2016151069971827444228
   PubMed Web of Science ®Google Scholar
• SprattDEZumstegZSFengFYTomlinsSATranslational and clinical implications of the genetic landscape of prostate cancerNat Rev Clin Oncol2016131059761027245282
   PubMed Web of Science ®Google Scholar
• LeeJKPhillipsJWSmithBAN-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cellsCancer Cell201629453654727050099
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research NetworkThe molecular taxonomy of primary prostate cancerCell201516341011102526544944
   PubMed Web of Science ®Google Scholar
• ZhaoJStockwellTRoemerAChikritzhsTIs alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysisBMC Cancer201616184527842506
   PubMed Web of Science ®Google Scholar
• KellySPGraubardBIAndreottiGYounesNClearySDCookMBPrediagnostic body mass index trajectories in relation to prostate cancer incidence and mortality in the PLCO cancer screening trialJ Natl Cancer Inst20171093djw22527754927
   PubMedGoogle Scholar
• NayanMHamiltonRJMacdonaldEMCanadian Drug Safety and Effectiveness Research Network (CDSERN)Vasectomy and risk of prostate cancer: population based matched cohort studyBMJ2016355i554627811008
   PubMed Web of Science ®Google Scholar
• ReynoldsJRayDAlexanderMYBruceIRole of vitamin D in endothelial function and endothelial repair in clinically stable systemic lupus erythematosusLancet2015385suppl 1S8326312905
   PubMedGoogle Scholar
• ChristakosSDhawanPVerstuyfAVerlindenLCarmelietGVitamin D: metabolism, molecular mechanism of action, and pleiotropic effectsPhysiol Rev201696136540826681795
   PubMed Web of Science ®Google Scholar
• LangerJPenna-MartinezMBonDHerrmannEWallaschMBadenhoopKInsufficient vitamin D response to solar radiation in German patients with type 2 diabetes or gestational diabetesHorm Metab Res201648850350827525476
   PubMed Web of Science ®Google Scholar
• Maia-CecilianoTCBarreto-ViannaARBarbosa-da-SilvaSAguilaMBFariaTSMandarim-de-LacerdaCAMaternal vitamin D-restricted diet has consequences in the formation of pancreatic islet/insulin-signaling in the adult offspring of miceEndocrine2016541606927142413
   PubMed Web of Science ®Google Scholar
• KellyJLSallesGGoldmanBLow serum vitamin D levels are associated with inferior survival in follicular lymphoma: a prospective evaluation in SWOG and LYSA studiesJ Clin Oncol201533131482149025823738
   PubMed Web of Science ®Google Scholar
• NyameYAMurphyABBowenDKAssociations between serum vitamin D and adverse pathology in men undergoing radical prostatectomyJ Clin Oncol201634121345134926903577
   PubMed Web of Science ®Google Scholar
• FeldmanDKrishnanAVSwamiSGiovannucciEFeldmanBJThe role of vitamin D in reducing cancer risk and progressionNat Rev Cancer201414534235724705652
   PubMed Web of Science ®Google Scholar
• GarlandCFGorhamEDDose–response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: a meta-analysisJ Steroid Biochem Mol Biol20161681827993551
   PubMed Web of Science ®Google Scholar
• ZhaoYChenCPanWComparative efficacy of vitamin D status in reducing the risk of bladder cancer: a systematic review and network meta-analysisNutrition201632551552326822497
   PubMed Web of Science ®Google Scholar
• BraunMMHelzlsouerKJHollisBWComstockGWProstate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)Cancer Causes Control1995632352397612803
   PubMed Web of Science ®Google Scholar
• NomuraAMStemmermannGNLeeJSerum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)Cancer Causes Control1998944254329794175
   PubMed Web of Science ®Google Scholar
• BaronJABeachMWallaceKRisk of prostate cancer in a randomized clinical trial of calcium supplementationCancer Epidemiol Biomarkers Prev200514358658915767334
   PubMed Web of Science ®Google Scholar
• BarnettCMNielsonCMShannonJSerum 25-OH vitamin D levels and risk of developing prostate cancer in older menCancer Causes Control20102181297130320383574
   PubMed Web of Science ®Google Scholar
• BrandstedtJAlmquistMManjerJMalmJVitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case–control studyCancer Causes Control20122381377138522706676
   PubMed Web of Science ®Google Scholar
• MeyerHERobsahmTEBjorgeTBrustadMBlomhoffRVitamin D, season, and risk of prostate cancer: a nested case–control study within Norwegian health studiesAm J Clin Nutr201397114715423193007
   PubMed Web of Science ®Google Scholar
• KristalARTillCSongXPlasma vitamin D and prostate cancer risk: results from the selenium and vitamin E cancer prevention trialCancer Epidemiol Biomarkers Prev20142381494150424732629
   PubMed Web of Science ®Google Scholar
• SkaabyTHusemoenLLThuesenBHProspective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancerCancer Epidemiol Biomarkers Prev20142371220122924789846
   PubMed Web of Science ®Google Scholar
• SawadaNInoueMIwasakiMPlasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested case–control study in Japan: the JPHC studyEur J Clin Nutr201771113213627759068
   PubMed Web of Science ®Google Scholar
• SchenkJMTillCATangenCMSerum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the prostate cancer prevention trialCancer Epidemiol Biomarkers Prev20142381484149325085836
   PubMed Web of Science ®Google Scholar
• AlbanesDMondulAMYuKSerum 25-hydroxy vitamin D and prostate cancer risk in a large nested case–control studyCancer Epidemiol Biomarkers Prev20112091850186021784952
   PubMed Web of Science ®Google Scholar
• AuneDGreenwoodDCChanDSBody mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studiesAnn Oncol201223484385221890910
   PubMed Web of Science ®Google Scholar
• HamlingJLeePWeitkunatRAmbuhlMFacilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease categoryStat Med200827795497017676579
   PubMed Web of Science ®Google Scholar
• WellsGASheaBO’ConnellDThe Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses2015 Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.aspAccessed September 28, 2017
   Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• GreenlandSLongneckerMPMethods for trend estimation from summarized dose–response data, with applications to meta-analysisAm J Epidemiol199213511130113091626547
   PubMed Web of Science ®Google Scholar
• OrsiniNLiRWolkAKhudyakovPSpiegelmanDMeta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and softwareAm J Epidemiol20121751667322135359
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• CrippaAOrsiniNMultivariate dose–response meta-analysis: the dosresmeta R packageJ Stat Softw201672Code Snippet 115
   Web of Science ®Google Scholar
• AtoumMFAlKateebDAlHaj MahmoudSAThe Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian menAsian Pac J Cancer Prev20151662227223025824742
   PubMedGoogle Scholar
• ChooCSMamedovAChungMChooRKissADanjouxCVitamin D insufficiency is common in patients with nonmetastatic prostate cancerNutr Res2011311212621310302
   PubMed Web of Science ®Google Scholar
• FangFKasperzykJLShuiIPrediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancerPLoS One201164e1862521494639
   PubMed Web of Science ®Google Scholar
• GalunskaBGerovaDKosevPAnakievskiDHinevASerum 25-hydroxy vitamin D levels in Bulgarian patients with prostate cancer: a pilot studyClin Lab2015613–432933525975000
   PubMed Web of Science ®Google Scholar
• GilbertRMartinRMFraserWDPredictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment studyCancer Causes Control201223457558822382867
   PubMed Web of Science ®Google Scholar
• GilbertRMetcalfeCFraserWDAssociations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoringEur J Cancer Prev201322212112522955340
   PubMed Web of Science ®Google Scholar
• GrantWBA multicountry ecologic study of risk and risk reduction factors for prostate cancer mortalityEur Urol200445327127915036670
   PubMed Web of Science ®Google Scholar
• GrantWBThe roles of ultraviolet-B irradiance, vitamin D, apolipoprotein E epsilon4, and diet in the risk of prostate cancerCancer Causes Control201122115715821052818
   PubMed Web of Science ®Google Scholar
• HendricksonWKFlavinRKasperzykJLVitamin D receptor protein expression in tumor tissue and prostate cancer progressionJ Clin Oncol201129172378238521537045
   PubMed Web of Science ®Google Scholar
• JacksonMDTulloch-ReidMKLindsayCMBoth serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestryCancer Med20154692593525858172
   PubMed Web of Science ®Google Scholar
• JohnEMSchwartzGGKooJVan Den BergDInglesSASun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancerCancer Res200565125470547915958597
   PubMed Web of Science ®Google Scholar
• MurphyABNyameYMartinIKVitamin D deficiency predicts prostate biopsy outcomesClin Cancer Res20142092289229924789033
   PubMed Web of Science ®Google Scholar
• NelsonSMBataiKAhaghotuCAgurs-CollinsTKittlesRAAssociation between serum 25-hydroxy-vitamin D and aggressive prostate cancer in African American menNutrients20169112
   Web of Science ®Google Scholar
• PallerCJKanaanYMBeyeneDARisk of prostate cancer in African-American men: evidence of mixed effects of dietary quercetin by serum vitamin D statusProstate201575131376138326047130
   PubMed Web of Science ®Google Scholar
• PazdioraPSvobodovaSFuchsovaRVitamin D in colorectal, breast, prostate and lung cancer: a pilot studyAnticancer Res201131103619362121965787
   PubMed Web of Science ®Google Scholar
• RocaEValcamonicoFAmorosoVSerum vitamin D and prostate cancer prognosis: the story continuesJ Clin Oncol2016343037093710
   Web of Science ®Google Scholar
• SchwartzGGVitamin D in blood and risk of prostate cancer: lessons from the selenium and vitamin E cancer prevention trial and the prostate cancer prevention trialCancer Epidemiol Biomarkers Prev20142381447144925085835
   PubMed Web of Science ®Google Scholar
• SteckSEArabLZhangHAssociation between plasma 25-hydroxyvitamin D, ancestry and aggressive prostate cancer among African Americans and European Americans in PCaPPLoS One2015104e012515125919866
   PubMed Web of Science ®Google Scholar
• StephanCLeinMMatalonJSerum vitamin D is not helpful for predicting prostate cancer aggressiveness compared with the prostate health indexJ Urol2016196370971426976204
   PubMed Web of Science ®Google Scholar
• TrumpDLChadhaMKSungaAYVitamin D deficiency and insufficiency among patients with prostate cancerBJU Int2009104790991419426195
   PubMed Web of Science ®Google Scholar
• TsengMBreslowRAGraubardBIZieglerRGDairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohortAm J Clin Nutr20058151147115415883441
   PubMed Web of Science ®Google Scholar
• YaturuSZdunekSYoungbergBVitamin D levels in subjects with prostate cancer compared to age-matched controlsProstate Cancer2012201252420623304521
   PubMedGoogle Scholar
• AhnJPetersUAlbanesDProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project TeamSerum vitamin D concentration and prostate cancer risk: a nested case–control studyJ Natl Cancer Inst20081001179680418505967
   PubMedGoogle Scholar
• Faupel-BadgerJMDiawLAlbanesDVirtamoJWoodsonKTangreaJALack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish menCancer Epidemiol Biomarkers Prev200716122784278618086789
   PubMed Web of Science ®Google Scholar
• JacobsETGiulianoARMartinezMEHollisBWReidMEMarshallJRPlasma levels of 25-hydroxyvitamin D, 125-dihydroxyvitamin D and the risk of prostate cancerJ Steroid Biochem Mol Biol200489–901–5533537
   Web of Science ®Google Scholar
• ParkSYCooneyRVWilkensLRMurphySPHendersonBEKolonelLNPlasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohortEur J Cancer201046593293620064705
   PubMed Web of Science ®Google Scholar
• PlatzEALeitzmannMFHollisBWWillettWCGiovannucciEPlasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancerCancer Causes Control200415325526515090720
   PubMed Web of Science ®Google Scholar
• ShuiIMMucciLAKraftPVitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case–control studyJ Natl Cancer Inst2012104969069922499501
   PubMedGoogle Scholar
• TravisRCCroweFLAllenNESerum vitamin D and risk of prostate cancer in a case–control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)Am J Epidemiol2009169101223123219359375
   PubMed Web of Science ®Google Scholar
• TuohimaaPTenkanenLAhonenMBoth high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case–control study in the Nordic countriesInt J Cancer2004108110410814618623
   PubMed Web of Science ®Google Scholar
• Bandera MerchanBMorcilloSMartin-NunezGTinahonesFJMacias-GonzalezMThe role of vitamin D and VDR in carcinogenesis: through epidemiology and basic sciencesJ Steroid Biochem Mol Biol201616720321827913313
   PubMed Web of Science ®Google Scholar
• TrummerCPandisMVerheyenNBeneficial effects of UV-radiation: vitamin D and beyondInt J Environ Res Public Health201613101028
   Web of Science ®Google Scholar
• BataiKMurphyABNonnLKittlesRAVitamin D and immune response: implications for prostate cancer in African AmericansFront Immunol201675326941739
   PubMed Web of Science ®Google Scholar
• IniestaRRPaciarottiIDavidsonI5-Hydroxyvitamin D concentration in paediatric cancer patients from Scotland: a prospective cohort studyBr J Nutr2016116111926193427974067
   PubMed Web of Science ®Google Scholar
• ShanNLWahlerJLeeHJVitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancerJ Steroid Biochem Mol Biol201617312212927923595
   PubMed Web of Science ®Google Scholar
• LuanZMaYXinYQianJWangHPossible molecular mechanisms by which vitamin D prevents inflammatory bowel disease and colitis-associated colorectal cancerCurr Med Chem2016249911917
   Web of Science ®Google Scholar
• ChanJMStampferMJGiovannucciEPlasma insulin-like growth factor-I and prostate cancer risk: a prospective studyScience199827953505635669438850
   PubMed Web of Science ®Google Scholar
• ChanJMStampferMJMaJInsulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancerJ Natl Cancer Inst200294141099110612122101
   PubMed Web of Science ®Google Scholar
• StattinPBylundARinaldiSPlasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective studyJ Natl Cancer Inst200092231910191711106682
   PubMedGoogle Scholar
• HypponenEBoucherBJBerryDJPowerC25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth CohortDiabetes200857229830518003755
   PubMed Web of Science ®Google Scholar